Orchid Pharma consolidated net profit rises 287.75% in the December 2023 quarter

Sales rise 38.08% to Rs 220.59 crore

Net profit of Orchid Pharma rose 287.75% to Rs 29.43 crore in the quarter ended December 2023 as against Rs 7.59 crore during the previous quarter ended December 2022. Sales rose 38.08% to Rs 220.59 crore in the quarter ended December 2023 as against Rs 159.76 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales220.59159.76 38 OPM %16.048.55 -PBDT39.4614.91 165 PBT30.196.73 349 NP29.437.59 288

Powered by Capital Market - Live News